Bacterial vaginosis (BV) is not officially classified as a sexually transmitted infection, but the relationship between BV and sex is complicated enough that the question deserves more than a simple no. BV is strongly associated with sexual activity, can spread between female sexual partners, and occurs most often in people who are sexually active. Yet it lacks the defining feature of a classic STI: a single infectious organism passed from one person to another.
Why BV Doesn’t Fit the STI Definition
Traditional STIs like chlamydia, gonorrhea, and syphilis are caused by a specific pathogen. You catch the organism from a partner, it infects you, and it can be identified and treated. BV doesn’t work this way. Rather than being caused by one invading germ, BV is a shift in the entire microbial ecosystem of the vagina. The normally dominant protective bacteria (lactobacilli) get outnumbered by a mix of various anaerobic bacteria that are already present in smaller amounts. Because no single organism causes BV, it doesn’t follow the standard model of infectious disease transmission.
This is the core reason medical authorities don’t label it an STI. The CDC states plainly that researchers do not know the cause of BV and do not fully understand how sex contributes to it. Some researchers have proposed that BV isn’t really an “infection” at all, but rather a reorganization of vaginal bacteria triggered by outside disruptions, including the introduction of oral or gut bacteria during various sexual practices.
The Strong Link to Sexual Activity
Even though BV isn’t classified as an STI, sex is one of the clearest risk factors. BV occurs most often in people who are sexually active, and certain sexual behaviors increase the likelihood of developing it. One proposed mechanism is surprisingly simple: semen is highly alkaline, and the vagina is naturally acidic. Repeated exposure to semen can raise vaginal pH, creating conditions where anaerobic bacteria thrive and lactobacilli decline. New or multiple sexual partners also increase risk, likely because each partner introduces a different microbial mix.
The connection is especially clear between female sexual partners. The CDC notes that BV can spread between women who have sex with women, and concordance rates (both partners having BV at the same time) tend to be high. This suggests that direct transfer of vaginal bacteria plays a role, which looks a lot like sexual transmission even if the condition itself isn’t a traditional STI.
Male partners of women with BV, on the other hand, do not need treatment. This asymmetry is another reason BV sits in a gray zone. If it were a straightforward STI, treating both partners would be standard practice, as it is with chlamydia or gonorrhea.
What Actually Happens in the Vagina
A healthy vaginal microbiome is dominated by lactobacilli, bacteria that produce hydrogen peroxide and lactic acid to keep the environment acidic (typically below a pH of 4.5). This acidity suppresses the growth of harmful organisms. When that balance tips, a diverse group of anaerobic bacteria can flourish, forming a sticky biofilm on the vaginal lining. These bacteria produce toxins that damage vaginal cells and release compounds that create the characteristic fishy odor associated with BV.
Because BV involves a whole community of bacteria rather than a single pathogen, it behaves differently from STIs in another important way: it can develop without any sexual contact at all. Anything that disrupts the vaginal ecosystem can potentially trigger it.
Other Risk Factors Beyond Sex
Douching is one of the most well-documented non-sexual risk factors. Women who douche at least once a month have a 1.4 times higher risk of developing BV compared to those who don’t. For women who douched within a week of being studied, the risk jumped to 2.1 times higher. Douching disrupts the hydrogen peroxide and lactobacilli that protect the vagina, allowing the anaerobic bacteria behind BV to take over.
Other factors that can shift the vaginal microbiome include antibiotic use (which can kill off protective lactobacilli along with targeted bacteria), hormonal changes, smoking, and the use of scented soaps or products inside the vagina. Some people develop BV repeatedly with no clear trigger at all.
Symptoms and How BV Is Diagnosed
Many people with BV have no symptoms. When symptoms do appear, the most common ones are a thin, grayish-white discharge with a milky consistency and a noticeable fishy smell, which often becomes stronger after sex. Some people also experience mild itching or burning during urination, though these symptoms overlap with yeast infections and other conditions, making self-diagnosis unreliable.
A clinical diagnosis typically requires at least three of four signs: the characteristic thin discharge, a vaginal pH above 4.5, the presence of “clue cells” (vaginal cells coated with bacteria visible under a microscope), and a fishy odor when the discharge is exposed to a chemical solution. Your provider may also use a lab-based test that analyzes the types of bacteria present.
Treatment and the Recurrence Problem
BV is treated with antibiotics, usually taken orally or applied as a vaginal gel or cream. Most cases clear up within a week of treatment. The bigger challenge is keeping it from coming back. Between 50% and 80% of women experience a BV recurrence within a year of completing antibiotic treatment. This high recurrence rate is one more way BV differs from typical STIs, which generally stay gone once treated (assuming you aren’t re-exposed).
The recurrence pattern likely reflects BV’s nature as a microbial imbalance rather than a single infection. Antibiotics can knock back the overgrown bacteria, but they don’t guarantee that lactobacilli will recolonize and maintain dominance. If the underlying conditions that disrupted the microbiome persist, whether that’s douching, a new sexual partner, or something else entirely, the imbalance can return.
Why the Classification Matters
Whether BV is called an STI has real consequences for how people think about it and how it’s managed. Labeling it an STI could increase stigma and lead to unnecessary partner treatment. On the other hand, downplaying the sexual connection might cause people to overlook practical steps that reduce risk, like using condoms (which limit semen exposure and reduce the exchange of bacteria) or being aware that female partners can share vaginal bacteria.
The most accurate way to think about BV is as a sexually associated condition. Sex is a major trigger, but it’s not the only one, and BV doesn’t spread the way a classic STI does. If you’re experiencing symptoms, testing matters because BV left untreated can increase susceptibility to actual STIs and cause complications during pregnancy.